These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. B-cell depleting agents for ANCA vasculitides: a new therapeutic approach. Gómez-Puerta JA; Quintana LF; Stone JH; Ramos-Casals M; Bosch X Autoimmun Rev; 2012 Jul; 11(9):646-52. PubMed ID: 22146313 [TBL] [Abstract][Full Text] [Related]
8. ANCA-associated vasculitides: advances in pathophysiology and treatment. Erwig LP; Savage CO Neth J Med; 2010 Feb; 68(2):62-7. PubMed ID: 20167957 [TBL] [Abstract][Full Text] [Related]
10. ANCA vasculitis: time for a change in treatment paradigm? Not yet. Ntatsaki E; Mooney J; Watts RA Rheumatology (Oxford); 2011 Jun; 50(6):1019-24. PubMed ID: 21292735 [TBL] [Abstract][Full Text] [Related]
14. The antineutrophil cytoplasmic antibody-associated vasculitides. Seo P; Stone JH Am J Med; 2004 Jul; 117(1):39-50. PubMed ID: 15210387 [TBL] [Abstract][Full Text] [Related]
15. Use of methotrexate in ANCA-associated vasculitides. Reinhold-Keller E; de Groot K Clin Exp Rheumatol; 2010; 28(5 Suppl 61):S178-82. PubMed ID: 21044456 [TBL] [Abstract][Full Text] [Related]
16. Issues associated with the Ministry of Health, Labour and Welfare diagnostic criteria for antineutrophil cytoplasmic antibody-associated vasculitides: Reclassification of patients in the prospective cohort study of Remission Induction Therapy in Japanese patients with ANCA-associated vasculitides according to the MHLW criteria. Sada KE; Yamamura M; Harigai M; Fujii T; Arimura Y; Makino H; Mod Rheumatol; 2015 Jul; 25(4):657-9. PubMed ID: 25496407 [No Abstract] [Full Text] [Related]
17. Recent advances to achieve remission induction in antineutrophil cytoplasmic antibody-associated vasculitis. Harper L Curr Opin Rheumatol; 2010 Jan; 22(1):37-42. PubMed ID: 19770660 [TBL] [Abstract][Full Text] [Related]
18. [Review article: Antineutrophil cytoplasmic antibody in small vessel vasculitis]. Nakano H; Ozaki S Rinsho Byori; 2010 May; 58(5):480-9. PubMed ID: 20560457 [TBL] [Abstract][Full Text] [Related]
19. Off-trial evaluation of the B cell-targeting treatment in the refractory cases of antineutrophil cytoplasmic antibodies (ANCA)-associated vasculitis: long-term follow-up from a single centre. Pullerits R; Ljevak M; Vikgren J; Bokarewa M Scand J Immunol; 2012 Oct; 76(4):411-20. PubMed ID: 22823472 [TBL] [Abstract][Full Text] [Related]
20. Post-influenza vaccination vasculitides: a possible new entity. Zafrir Y; Agmon-Levin N; Shoenfeld Y J Clin Rheumatol; 2009 Sep; 15(6):269-70. PubMed ID: 19734729 [No Abstract] [Full Text] [Related] [Next] [New Search]